D. Mezebish et al., NEUROCRISTIC CUTANEOUS HAMARTOMA - A DISTINCTIVE DERMAL MELANOCYTOSISWITH AN UNKNOWN MALIGNANT POTENTIAL, Modern pathology, 11(6), 1998, pp. 573-578
Neurocristic hamartomas (NCHs) result from aberrant development of the
neuromesenchyme. In addition to a dermal melanocytic component, these
tumors can contain neurosustentacular and fibrogenic components and c
an undergo malignant transformation. Although NCHs have many features
in common with Other dermal melanocytic neoplasms, including cellular
blue nevi and some congenital nevi, they have distinctive clinical and
histologic features. We present a case report of a 27-year-old white
woman with an NCH of the scalp. The clinical, histologic, and immunohi
stochemical features are compared with those of other dermal melanocyt
ic neoplasms. The NCH contained epithelioid pigmented melanocytes posi
tive for S-100 and HMB45, within which there were well-circumscribed n
odules of S-100+/Leu 7+/HMB45- cells surrounded by a capsule composed
of spindle cells positive for epithelial membrane antigen. The stromal
cells throughout the tumor were diffusely CD34 positive, and hair fol
licles were decreased and dystrophic within the tumor. NCHs represent
neoplastic dysplasia that involves not only melanocytic cells but also
neurosustentacular and fibrocytic effector cells. The histologic and
immunohistochemical features, along with the decreased and dystrophic
hair follicles, suggest that the abnormalities in the mesenchyme are s
ignificant and result from the contribution of neural crest cells to t
he cellular and matrix components of the mesenchyme.